For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...

Mineralys Therapeutics announced positive topline results from its phase 2 Explore-CKD trial, in which lorundrostat lowered ...

HealthDay News — Hypertension is the most common chronic condition among adults aged 85 years and older, with prevalence higher among women than men, according to a report published in the June Health ...

Pregnancy can be an exciting time, but can also come with unexpected challenges as you prepare to welcome a new addition to ...

A comprehensive new study from the Centers for Disease Control and Prevention’s National Center for Health Statistics shows that chronic health conditions are nearly universal among Americans age 85 ...

Persistent high blood pressure, or resistant hypertension, requires a proactive and personalized approach beyond just ...

High blood pressure is caused by a combination of factors, such as age, dietary habits, and coexisting conditions. Learn ...

A new study has found a link between certain midlife vascular risk factors — specifically high blood pressure, diabetes, and ...

The federal government has disclosed that many cases of hypertension in Nigeria remain undiagnosed, significantly ...

The Federal Government has raised concerns that many cases of hypertension in Nigeria remain undiagnosed, significantly ...

Merck said that a phase-three study of its pulmonary arterial hypertension treatment met its primary endpoints.

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...